Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • SDPA_Pet
    Senior Member
    • Apr 2013
    • 222

    #1

    What does exactly the contig coverage mean?

    Can anyone give the definition about "contig coverage" mean? I am confused about it? Does it mean the number of reads used to assembled to this particular contig?

    I also hear coverage? When you do illumina sequencing. What does coverage in sequencing mean? How can you calculate it?

    Do these two coverage use the same calculation method?

    Thanks.
  • jmartin
    Member
    • Dec 2009
    • 78

    #2
    Its usually best if you can ask the person providing that value what exactly they mean if you aren't sure since there are a number of legitimate ways people use the word 'coverage'.

    My naive assumption when someone says 'contig coverage' is that they are talking about the average number of reads spanning each given base position. This value would have been calculated by taking the total no. of bases that map to the contig divided by the contig length. And if the value is an average across many contigs, then its taking the total no. of bases mapping to all contigs divided by the total length of all contigs.

    I think when someone is talking about a request for illumina sequencing, and they talk about wanting '200x' coverage worth of illumina sequencing, in that context they are talking about the total number of bases of sequencing they will produce divided by the estimated length of the genome. This coverage value is much more of an estimate than one based on actual mapping (or the internal knowledge of how many reads span each position that an assembler may report as a post-assembly metric). So a request for 100x illumina coverage of a 50Mb genome means you want enough illumina runs to generate 5000Mb of illumina read data. This coverage value can often differ from what you find after you actually assemble the data. If your genome size estimate was wrong, or of the assembly is bad, you may find that the actual 'coverage' you have of the genome will be different from your initial estimate.

    I am making a lot of assumptions here, but these would be my guess at what people mean when they are talking about the coverages you are asking about.

    Comment

    • SDPA_Pet
      Senior Member
      • Apr 2013
      • 222

      #3
      Hi Jmartin,

      Thanks. I think the contig coverage explanation is what I need.

      For the sequencing coverage, your example is for a genome. I am doing environmental metagenome. So, the sequencing coverage doesn't apply for my case, because I don't have the prior knowledge about my metageome. I don't know how large it is.

      Comment

      • jmartin
        Member
        • Dec 2009
        • 78

        #4
        Hmm, yeah I wouldn't know what exactly someone meant by 'illumina coverage' for a metagenomic sample. Unless you already know the community makeup and know the genome sizes. And even then the composition of the community would make it tricky since some genomes may be present in abundance and others may be rare.

        Sorry, hopefully someone more in the know will reply.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
          by SEQadmin2



          Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

          Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
          ...
          10-14-2026, 09:55 AM
        • SEQadmin2
          New Genomics Technologies Take Aim at Long-Standing Limits
          by SEQadmin2


          Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

          We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
          ...
          09-28-2026, 10:25 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Yesterday, 11:13 AM
        0 responses
        19 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, Yesterday, 10:48 AM
        0 responses
        18 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-15-2026, 10:52 AM
        0 responses
        36 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-14-2026, 05:39 AM
        0 responses
        42 views
        0 reactions
        Last Post SEQadmin2  
        Working...